FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Strained by Covid, CDRH Wants More MDUFA Money

[ Price : $8.95]

CDRH seeks a boost to its resources as it negotiates the reauthorization of the Medical Device User Fee Act (MDUFA) program, claim...

Med-Pharmx Selling Adulterated Animal Drugs: DoJ

[ Price : $8.95]

The Justice Department asks a California federal court for an injunction to prevent Med-Pharmx from manufacturing and distributing...

Orally Inhaled Nicotine Drug Product Nonclinical Testing

[ Price : $8.95]

FDA issues a guidance on nonclinical information to support the development and approval of orally inhaled nicotine-containing dru...

Praise for Nervous System Metastases Draft Guidance

[ Price : $8.95]

Four drug companies recommend technical changes to an FDA draft guidance on evaluating cancer drugs in patients with central nervo...

Guidance on Automated External Defibrillator Accessories

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Necessary Automated External Defibrillator Accessories: Pol...

ANDA Reference Products Guidance

[ Price : $8.95]

Federal Register Notice: FDA makes available a final guidance on how to reference Approved drug products in ANDA submissions.

Artificial Intelligence Committee Meeting Notes

[ Price : $8.95]

FDA releases a meeting summary with recommendations on artificial intelligence and machine learning from the Patient Engagement Ad...

MAPP on REMS Development

[ Price : $8.95]

CDER publishes a MAPP on responsibilities and procedures for developing two types of REMS.

Guide on Monitoring Devices Enforcement Policy

[ Price : $8.95]

FDA posts a revised guidance on its enforcement policy for Remote Monitoring Devices Used During Covid-19 Emergency.

Guide on Tobacco Product Perception/Intention Studies

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance conducting tobacco product perception and intention studies.